Association between HBeAg seroconversion and sustained HBV-DNA suppression in patients treated with peginterferon alpha-2a (40KD) (PEGASYS) for HBeAg-positive chronic hepatitis B (CHB)

被引：3
|
作者：
Piratvisuth, T.
Lau, G. K. K.
Marcellin, P.
Chow, W. C.
Cooksley, G.
Fried, M. W.
Paik, S. W.
Liaw, Y. F.
Popescu, M.
Button, P.
机构：
[1] Prince Songkla Univ, Dept Internal Med, Songklanagarind Hosp, Hat Yai, Thailand
[2] Univ Hong Kong, Queen Marys Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China
[3] Hop Beaujon, Serv Hepatol, Clichy, France
[4] Singapore Gen Hosp, Dept Gastroenterol, Singapore 0316, Singapore
[5] Royal Brisbane Hosp, Dept Clin Res, Brisbane, Qld 4029, Australia
[6] Univ N Carolina, Univ N Carolina Liver Program, Chapel Hill, NC USA
[7] Samsung Med Ctr, Dept Gastroenterol, Seoul, South Korea
[8] Chang Gung Mem Hosp, Linkou, Taiwan
来源：
JOURNAL OF HEPATOLOGY | 2006年 / 44卷
关键词：
D O I：
10.1016/S0168-8278(06)80050-4
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
49
引用
收藏
页码：S23 / S23
页数：1
相关论文
共 50 条
  • [21] IMPROVED PREDICTIVE VALUE FOR SUSTAINED IMMUNE CONTROL IN PEGINTERFERON ALFA-2A (40KD) (PEGASYS)-TREATED HBEAG-POSITIVE PATIENTS USING COMBINED HBSAG AND HBV DNA LEVELS AT WEEK 24
    Piratvisuth, T.
    Chan, H. L. Y.
    Marcellin, P.
    Wat, C.
    Regep, L.
    Messinger, D.
    Kapprell, H. -P.
    Lu, Z. M.
    Luo, K. X.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S213 - S214
  • [22] Sustained response to peginterferon alfa-2a (40 kD) with or without lamivudine in Asian patients with HBeAg-positive and HBeAg-negative chronic hepatitis B
    Piratvisuth, Teerha
    Lau, George
    Chao, You-Chen
    Jin, Rui
    Chutaputti, Anuchit
    Zhang, Q. -B.
    Tanwandee, Tawesak
    Button, Peter
    Popescu, Matei
    HEPATOLOGY INTERNATIONAL, 2008, 2 (01) : 102 - 110
  • [23] HBV pregenome RNA as a predictor of spontanous HBeAg seroconversion in HBeAg-positive chronic hepatitis B patients
    Guangjun Song
    Ruifeng Yang
    Qian Jin
    Juan Liu
    Huiying Rao
    Bo Feng
    Yandi Xie
    BMC Gastroenterology, 23
  • [24] Sustained response to peginterferon alfa-2a (40 kD) with or without lamivudine in Asian patients with HBeAg-positive and HBeAg-negative chronic hepatitis B
    Teerha Piratvisuth
    George Lau
    You-Chen Chao
    Rui Jin
    Anuchit Chutaputti
    Q.-B. Zhang
    Tawesak Tanwandee
    Peter Button
    Matei Popescu
    Hepatology International, 2008, 2 : 102 - 110
  • [25] CHANGES IN HBEAG LEVELS AMONG PATIENTS WITH HBEAG-POSITIVE CHRONIC HEPATITIS B TREATED WITH PEGINTERFERON ALFA-2A [40KD] ENROLLED IN THE S-COLLATE COHORT STUDY
    Lou, GuoQiang
    Marcellin, Patrick
    Xie, Yao
    Chen, Xiao P.
    Chen, Yong-Ping
    Rothe, Vivien
    Regep, Loredana
    Martins, Eduardo B.
    Jia, Jidong
    Wei, Lai
    HEPATOLOGY, 2010, 52 (04) : 537A - 537A
  • [26] HBV pregenome RNA as a predictor of spontanous HBeAg seroconversion in HBeAg-positive chronic hepatitis B patients
    Song, Guangjun
    Yang, Ruifeng
    Jin, Qian
    Liu, Juan
    Rao, Huiying
    Feng, Bo
    Xie, Yandi
    BMC GASTROENTEROLOGY, 2023, 23 (01)
  • [27] COST-EFFECTIVENESS ANALYSIS OF PEGINTERFERON ALFA-2A (40KD) IN HBEAG-POSITIVE CHRONIC HEPATITIS B IN POLAND
    Jakubczyk, M.
    Paweska, J.
    Niewada, M.
    Berak, H.
    Szkultecka-Debek, M.
    Russel-Szymczyk, M.
    VALUE IN HEALTH, 2011, 14 (07) : A275 - A275
  • [28] Response and seroconversion rates among HBeAg-positive chronic HBV Egyptian patients treated with peginterferon alpha 2a (Pegasys), a single-centre experience
    Maklad, Sahar
    Esmat, Gamal
    Doss, Wahid
    Abou-Zeid, Alaa
    El-Din, Sameh Seif
    ARAB JOURNAL OF GASTROENTEROLOGY, 2013, 14 (02) : 73 - 77
  • [29] ALT flares and sustained ALT response in patients with HBeAg-negative chronic hepatitis B treated with peginterferon alfa-2a (40KD) (PEGASYS®), peginterferon alfa-2a (40KD) plus lamivudine or lamivudine alone
    Piratvisuth, T
    Marcellin, P
    Lau, G
    Bonino, F
    Farci, P
    Hadziyannis, S
    Jin, R
    Lu, ZM
    Germanidis, G
    Yurdaydin, C
    Diago, M
    Gurel, S
    Lai, MY
    Button, P
    Why, RD
    Pluck, N
    HEPATOLOGY, 2004, 40 (04) : 656A - 657A
  • [30] The effect of peginterferon alpha-2a vs. interferon alpha-2a on intrahepatic covalently closed circular DNA in HBeAg-positive chronic hepatitis B patients
    Liu, Sufen
    Zheng, Huanwei
    Huang, Yan
    Li, Bingshun
    Dong, Zhenghong
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2016, 40 (03) : 304 - 308
12345